Qureight is a UK-based healthtech company offering an end-to-end AI-powered imaging platform for clinical trials, with a specific focus on lung and heart diseases.
The company provides regulatory-compliant AI lung image biomarkers and data science products, including synthetic control arms and a 3D chest imaging foundation model, to support biopharma partners in clinical research.